Divergent outcomes in cognitive-behavioral therapy and pharmacotherapy for adult depression

American Journal of Psychiatry

Volumn 173, Issue 5, 2016, Pages 481-490

  Vittengl, Jeffrey R ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Jarrett, Robin B ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Weitz, Erica ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Hollon, Steven D ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Twisk, Jos ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Cristea, Ioana ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   David, Daniel ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   DeRubeis, Robert J ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Dimidjian, Sona ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Dunlop, Boadie W ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Faramarzi, Mahbobeh ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Hegerl, Ulrich ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Kennedy, Sidney H ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Kheirkhah, Farzan ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Mergl, Roland ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Miranda, Jeanne ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Mohr, David C ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Rush, A John ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Segal, Zindel V ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Siddique, Juned ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Simons, Anne D ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Cuijpers, Pim ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   more..

^a TRUMAN STATE UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d VANDERBILT UNIVERSITY   (United States)

^e BABE BOLYAI UNIVERSITY   (Romania)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

^g UNIVERSITY OF COLORADO   (United States)

^h EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ BABOL UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^j UNIVERSITY OF LEIPZIG   (Germany)

^k UNIVERSITY OF TORONTO   (Canada)

^l UNIVERSITY OF TORONTO   (Canada)

^m UNIVERSITY OF CALIFORNIA   (United States)

ⁿ NORTHWESTERN UNIVERSITY   (United States)

^o DUKE NUS MEDICAL SCHOOL   (Singapore)

^p UNIVERSITY OF NOTRE DAME   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; COGNITIVE BEHAVIORAL THERAPY; CONTROLLED STUDY; DETERIORATION; DISEASE SEVERITY; FEMALE; HAMILTON DEPRESSION RATING SCALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MIDDLE AGED; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; TREATMENT RESPONSE; COGNITIVE THERAPY; DEPRESSIVE DISORDER; DEPRESSIVE DISORDER, MAJOR; META ANALYSIS; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); YOUNG ADULT;

ANTIDEPRESSANT AGENT;

ADULT; ANTIDEPRESSIVE AGENTS; COGNITIVE THERAPY; DEPRESSIVE DISORDER; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; PSYCHIATRIC STATUS RATING SCALES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84965150449     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2015.15040492     Document Type: Article

References (40)

1. Cuijpers P, Berking M, Andersson G, et al: A meta-analysis of cognitive-behavioural therapy for adult depression, alone and in comparison with other treatments. Can J Psychiatry 2013; 58: 376-385
2. Iovieno N, Tedeschini E, Ameral VE, et al: Antidepressants for major depressive disorder in patients with a co-morbid axis-III disorder: A meta-analysis of patient characteristics and placebo response rates in randomized controlled trials. Int Clin Psychopharmacol 2011; 26:69-74
3. Cuijpers P, Karyotaki E, Weitz E, et al: The effects of psychotherapies for major depression in adults on remission, recovery and improvement: A meta-analysis. J Affect Disord 2014; 159: 118-126
4. Cuijpers P, Turner EH, Mohr DC, et al: Comparison of psychotherapies for adult depression to pill placebo control groups: A metaanalysis. Psychol Med 2014; 44:685-695
5. Dunlop BW, Thase ME, Wun CC, et al: A meta-analysis of factors impacting detection of antidepressant efficacy in clinical trials: The importance of academic sites. Neuropsychopharmacology 2012; 37: 2830-2836
6. Dimidjian S, Hollon SD: How would we know if psychotherapy were harmful? Am Psychol 2010; 65:21-33
7. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56-62
8. Zimmerman M, Posternak MA, Chelminski I: Is the cutoff to define remission on the Hamilton Rating Scale for Depression too high? J Nerv Ment Dis 2005; 193:170-175
9. Ogles BM, Lambert MJ, Sawyer JD: Clinical significance of the National Institute of Mental Health Treatment of Depression Collaborative Research Program data. J Consult Clin Psychol 1995; 63: 321-326
10. Coffman SJ, Martell CR, Dimidjian S, et al: Extreme nonresponse in cognitive therapy: Can behavioral activation succeedwherecognitive therapy fails? J Consult Clin Psychol 2007; 75:531-541
11. Linden M, Schermuly-Haupt ML: Definition, assessment and rate of psychotherapy side effects. World Psychiatry 2014; 13:306-309
12. Lambert MJ: Predicting negative treatment outcome: Methods and estimates of accuracy, in Prevention of Treatment Failure: The Use of Measuring, Monitoring, and Feedback in Clinical practice. Washington, DC, American Psychological Association, 2010, pp 83-105
13. Lambert MJ: The efficacy and effectiveness of psychotherapy, in Bergin and Garfield's Handbook of Psychotherapy and Behavior Change, 6th ed. Edited by Lambert MJ. New York, Wiley, 2013, pp 169-218
14. Blais MA, Malone JC, Stein MB, et al: Treatment as usual (TAU) for depression: A comparison of psychotherapy, pharmacotherapy, and combined treatment at a large academic medical center. Psychotherapy (Chic) 2013; 50:110-118
15. KoenigAM,JarrettRB, Gallop R, et al:Extremenonresponseto acute phase cognitive therapy for depression: An attempt to replicate and extend. Behav Ther 2014; 45:300-313
16. DeRubeis RJ, Cohen ZD, Forand NR, et al: The Personalized Advantage Index: Translating research on prediction into individualized treatment recommendations: A demonstration. PLoSOne 2014; 9:e83875
17. Jarrett RB, Minhajuddin A, Kangas JL, et al: Acute phase cognitive therapy for recurrent major depressive disorder: Who drops out and howmuchdo patient skills influence response?Behav Res Ther2013; 51:221-230
18. Driessen E, Hollon SD: Cognitive behavioral therapy for mood disorders: Efficacy, moderators and mediators. Psychiatr Clin North Am 2010; 33:537-555
19. Rush AJ, Wisniewski SR, Warden D, et al: Selecting among secondstep antidepressant medication monotherapies: Predictive value of clinical, demographic, or first-step treatment features. Arch Gen Psychiatry 2008; 65:870-880
20. Souery D, Oswald P, Massat I, et al: Clinical factors associated with treatment resistance in major depressive disorder: Results from a European multicenter study. J Clin Psychiatry 2007; 68:1062-1070
21. Tedlow J, Fava M, Uebelacker L, et al: Outcome definitions and predictors in depression. Psychother Psychosom 1998; 67:266-270
22. Van HL, Schoevers RA, Dekker J: Predicting the outcome of antidepressants and psychotherapy for depression: A qualitative, systematic review. Harv Rev Psychiatry 2008; 16:225-234
23. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 5th ed. Washington, DC, American Psychiatric Association, 2013
24. Beck AT, Haigh EA: Advances in cognitive theory and therapy: The generic cognitive model. Annu Rev Clin Psychol 2014; 10:1-24
25. Ma Y: Neuropsychological mechanism underlying antidepressant effect: A systematic meta-analysis. Mol Psychiatry 2015; 20:311-319
26. Beck AT, Ward CH, Mendelson M, et al: An inventory for measuring depression. Arch Gen Psychiatry 1961; 4:561-571
27. Beck AT, Steer RA, Brown GK: Beck Depression Inventory, Second Edition Manual. San Antonio, Tex, Psychological Corp, 1996
28. Grundy CT, LambertMJ, Grundy EM: Assessing clinical significance: Application to the Hamilton Rating Scale for Depression. J Ment Health 1996; 5:25-33
29. Seggar LB, Lambert MJ, Hansen NB: Assessing clinical significance: Application to the Beck Depression Inventory. Behav Ther 2002; 33: 253-269
30. Vittengl JR, Clark LA, Thase ME, et al: Nomothetic and idiographic symptom change trajectories in acute-phase cognitive therapy for recurrent depression. JConsultClin Psychol 2013; 81: 615-626
31. Cuijpers P, Weitz E, Twisk J, et al: Gender as predictor and moderator of outcome in cognitive behavior therapy and pharmacotherapy for adult depression: An "individual patient data" metaanalysis. Depress Anxiety 2014; 31:941-951
32. Weitz ES, Hollon SD, Twisk J, et al: Baseline depression severity as moderator of depression outcomes between cognitive behavioral therapy vs pharmacotherapy: An individual patient data metaanalysis. JAMA Psychiatry 2015; 72:1102-1109
33. Jarrett RB, Minhajuddin A, Gershenfeld H, et al: Preventing depressive relapse and recurrence in higher-risk cognitive therapy responders: A randomized trial of continuation phase cognitive therapy, fluoxetine, or matched pill placebo. JAMA Psychiatry 2013; 70:1152-1160
34. Boisvert CM, Faust D: Iatrogenic symptoms in psychotherapy: A theoretical exploration of the potential impact of labels, language, and belief systems. Am J Psychother 2002; 56:244-259
35. Dunlop BW, McCabe B, Eudicone JM, et al: How well do clinicians and patients agree on depression treatment outcomes? implications for personalized medicine. Hum Psychopharmacol 2014; 29: 528-536
36. Cusin C, Yang H, Yeung A, et al: Rating scales for depression, in Handbook of Clinical Rating Scales and Assessment in Psychiatry and Mental Health. Edited by Baer L, Blais MA. Totowa, NJ, Humana, 2010, pp 7-35
37. Hollon SD: Cognitive and behavior therapy in the treatment and prevention of depression. Depress Anxiety 2011; 28:263-266
38. Simon GE, Perlis RH: Personalized medicine for depression: Can we match patients with treatments? Am J Psychiatry 2010; 167: 1445-1455
39. Renner F, Cuijpers P, Huibers MJ: The effect of psychotherapy for depression on improvements in social functioning: A meta-analysis. Psychol Med 2014; 44:2913-2926
40. Mohr DC: Negative outcome in psychotherapy: A critical review. Clin Psychol Sci Pract 1995; 2:1-27